Microbot Medical (MBOT) Hisse Fiyat
Microbot Medical Fiyat
Microbot Medical, son 9 yılda gelirini yıllık %2,6 artırarak 117.000,00 USD seviyesine taşıdı. Microbot Medical için net marj, %-31.123,9 ile birkaç yıl önceki %-1.746,8 seviyesine göre geriledi. Microbot Medical için 12 aylık konsensüs fiyat hedefi 4,00 USD; bu, hissenin bugünkü fiyatının yaklaşık %296,0 üzerinde bir seviyeye denk geliyor. 9 analistten 8 tanesi hisse için alım öneriyor — genel konsensüs: Al.
Microbot Medical hisse senedi fiyatı
Bu verilere Eulerpool API üzerinden ulaşın
Ayda 100.000 ücretsiz istek · kredi kartı yok
Microbot Medical iş modeli ve hisse analizi
Microbot Medical hakkında sık sorulan sorular
Microbot Medical Inc's business model focuses on the development and commercialization of innovative transformational robotic solutions in the medical industry. The company specializes in creating miniature robots that can assist in minimally invasive surgeries, targeted drug delivery, and targeted endotherapy procedures. Microbot Medical Inc utilizes its proprietary technologies, including its Microbot Swarm system and ViRob robotic platform, to address critical unmet needs in various medical specialties. With its advanced robotic solutions, Microbot Medical Inc aims to improve patient outcomes, enhance surgical procedures, and provide physicians with more precise and efficient tools for diagnosis and treatment in the medical field.
Microbot Medical Inc is primarily active in the medical technology industry. As a cutting-edge company, Microbot Medical specializes in the development and commercialization of robotic technologies focused on improved medical procedures and treatments. With its innovative product portfolio, Microbot Medical aims to revolutionize various medical fields such as urology, neurology, and cardiovascular healthcare. Through its dedication to technological advancements and industry collaborations, Microbot Medical strives to provide healthcare professionals and patients with breakthrough solutions that enhance overall medical outcomes.
The main competitors of Microbot Medical Inc in the market include companies such as Medtronic, Intuitive Surgical, and Johnson & Johnson.
Microbot Medical Inc is a leading medical device company specializing in the development of transformational micro-robotic technologies. Established in 2010, Microbot Medical Inc aims to improve patient outcomes through the development of innovative robotic platforms designed for minimally invasive surgeries and targeted therapies. The company's cutting-edge technologies utilize advanced engineering and robotics to address significant unmet medical needs in various medical fields, including urology, gastroenterology, and ENT (ear, nose, and throat). With its commitment to revolutionizing medical interventions, Microbot Medical Inc continues to push boundaries in the field of robotic medicine, creating new possibilities for improved patient care.
Microbot Medical Inc has achieved several significant milestones. Firstly, the company successfully developed and received regulatory clearance for its innovative robotic technologies in the medical industry. Additionally, Microbot Medical Inc has made notable advancements in the fields of urology, neurology, and gastrointestinal procedures. The company has also successfully completed important clinical studies and collaborations with leading medical institutions. Moreover, Microbot Medical Inc has secured intellectual property rights for its proprietary technologies, which strengthens its position in the market. These milestones demonstrate the company's dedication to improving healthcare outcomes and solidify its reputation as a leader in the medical robotics field.
Microbot Medical Inc is primarily present in the United States, Israel, and Europe. This company, specializing in micro-robotics technologies, operates in multiple regions to distribute their innovative medical devices and solutions. Microbot Medical Inc's presence in these countries and regions enables them to reach a significant market and collaborate with leading medical institutions, professionals, and industry experts. By establishing a global footprint, Microbot Medical Inc aims to enhance patient outcomes and revolutionize the field of medical robotics.
Microbot Medical Inc represents values of innovation, advancement, and patient-centric healthcare solutions. With a strong corporate philosophy aimed at addressing unmet medical needs, Microbot Medical Inc is dedicated to developing and commercializing transformative robotic technologies. By combining novel engineering with medical expertise, the company aims to improve patient outcomes, reduce healthcare costs, and enhance overall quality of life. Microbot Medical Inc strives to empower physicians and healthcare professionals with cutting-edge tools and solutions, all while prioritizing patient safety and well-being.
Analistler şu anda Microbot Medical hissesi için ortalama 4,00 USD hedef fiyat belirliyor (medyan: 4,00 USD); bu, son fiyata göre +296,0 % anlamına gelir. Konsensüs 9 analist notuna dayanır.
9 analist şu anda Microbot Medical hissesini değerlendiriyor: 8 al, 1 tut, 0 sat öneriyor. 2026 için analistler Microbot Medical şirketinin 841.333,00 USD gelir ve -0,06 USD hisse başına kâr üretmesini bekliyor.
Güncel döviz kuruyla Microbot Medical hissesi 0,90 EUR (1,01 USD) seviyesindedir.
Microbot Medical hissesi (MBOT) 4 borsada işlem görür, bunlar arasında: NASDAQ (MBOT), Frankfurt (CY9D.F), München (CY9D.MU), Düsseldorf (CY9D.DU).
Microbot Medical Inc is a leading company in the development and commercialization of miniature robots for medical applications. The company is based in Israel and also has branches in the USA.
beklenen'nin Microbot Medical hasılatı 841.333,00 USD'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
beklenen'nin Microbot Medical karı -4,21 M USD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Microbot Medical'nin Fiyat/Kazanç (F/K) oranı şu anda -16,10'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Microbot Medical hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Microbot Medical'nin Fiyat/Satış (F/S) oranı şu anda 80,63'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Microbot Medical hisse senedinin değerleme metriği olarak hizmet eder.
Microbot Medical'nin Eulerpool Kalite Puanı 2/10'dur.
Microbot Medical'nin ISIN'i US59503A2042'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Microbot Medical'nin WKN'i A2N5AS'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.
Microbot Medical'nin ticker'ı MBOT'dir. Ticker sembolü, Microbot Medical hisseleri borsada işlem görmek için kullanılır.
Microbot Medical Hissesi
Microbot Medical Emsaller Grubu
Microbot Medical Ticker
Microbot Medical FIGI
Microbot Medical'nin tüm temel göstergeleri ve derinlemesine analizi
Microbot Medical hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Microbot Medical şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: